This suggests that although SOX30 inhibition contributes to miR-645-mediated CRC cell proliferation and survival, other unidentified targets of miR-645 may be more critical in executing the biological function of miR-645 in colon cancer. The gene discussed is SOX30; the disease is malignant colon neoplasm.